Market Size (2025)
$828.66M
Vertical: CNMBase Year: 2025
Market Size (2025)
$828.66M
Projected (2032)
$1.27B
CAGR (2022–2032)
6.9%
Key Players
10+
Market Overview
The global polysulfone market was valued at USD 828.66 Million in 2025 and is projected to reach USD 1,266.78 Million by 2032, registering a CAGR of 6.13% during 2026–2032. Over the historic period, the market expanded from USD 648.46 Million in 2022 to USD 768.55 Million in 2024, and between 2025 and 2032 it is expected to add USD 438.11 Million in absolute value.
Polysulfone is an amorphous, transparent high-performance thermoplastic valued for its combination of high heat resistance, hydrolytic stability, sterilisability, inherent flame resistance and dimensional stability. These properties make it a material of choice for haemodialysis and water-treatment membranes, sterilisable medical devices, electrical components, automotive and aerospace parts, and food-processing and plumbing equipment. Market growth over the forecast period will be underpinned by expanding healthcare access and dialysis treatment, investment in water treatment, reuse and desalination, vehicle electrification and the growth of electronics manufacturing, particularly in Asia Pacific.
Key Findings
By Grade: Unfilled was the largest grade in 2025, valued at USD 497.20 Million with a 60.0% share, while Glass-Filled is the fastest-growing grade at a CAGR of 6.78%.
By End-Use Industry: Medical & Healthcare was both the largest end-use industry, valued at USD 248.60 Million (30.0% share), and the fastest-growing, at a CAGR of 6.89%.
By Processing Method: Injection Molding was the largest processing method, valued at USD 580.06 Million (70.0% share), while Extrusion & Others is the fastest-growing at a CAGR of 6.82%.
By Region: Asia Pacific was the leading region, valued at USD 314.89 Million (38.0% share), while Middle East & Africa is the fastest-growing region at a CAGR of 7.64%.
By Country: The U.S. was the leading country market, valued at USD 203.85 Million in 2025, while India is the fastest-growing country at a CAGR of 9.41%.
Segmentation Summary
Grade: Unfilled grades dominate because the core polysulfone applications in membranes, medical devices and food-contact equipment rely on neat resin for transparency, toughness and biocompatibility. Glass-filled grades grow faster, at 6.78% compared with 5.68%, as metal replacement and electrification increase demand for stiff, dimensionally stable components; their share rises from 40.0% in 2025 to 41.8% in 2032.
End-Use Industry: Medical & Healthcare accounts for 30.0% of 2025 value and adds USD 150.94 Million between 2025 and 2032. Electrical & Electronics and Water & Food Processing each account for 25.0%, and Automotive & Aerospace accounts for 20.0%, growing at 6.02% on the back of vehicle electrification.
Processing Method: Injection moulding represents 70.0% of 2025 value, reflecting the dominance of precision moulded parts, while Extrusion & Others, which includes membrane spinning, film, sheet and stock shapes, grows faster at 6.82%.
Region: Asia Pacific is both the largest region and the source of the largest absolute growth, adding USD 193.08 Million between 2025 and 2032. North America (30.0% share) and Europe (28.0% share) are mature markets growing at 5.59% and 5.35% respectively, while Latin America and Middle East & Africa, each with a 2.0% share, grow fastest from small bases.
Competitive Landscape Summary
The global polysulfone market is moderately consolidated at the resin-production level. Two Western producers, Syensqo (formerly Solvay Specialty Polymers), with its Udel PSU, Veradel PESU and Radel PPSU ranges, and BASF, with its Ultrason S, E and P ranges, lead the market on the strength of integrated production, broad grade portfolios, long-standing medical, membrane and food-contact qualifications and global technical service. Sumitomo Chemical is an established Japanese producer of sulfone polymers, while Chinese producers such as Guangdong Youju Advanced New Materials, Kingfa Sci. & Tech. and Shandong Horann Advanced Materials have expanded capacity and are increasingly competitive in standard grades and in export markets.
Downstream, converters and formulators such as Ensinger, Mitsubishi Chemical Group (through Mitsubishi Chemical Advanced Materials), Röchling and Avient add value through stock shapes, machined parts and high-temperature colorants. Competition centres on regulatory documentation, application-development support, supply security and, increasingly, sustainability credentials, with leading producers launching ISCC PLUS mass-balance and bio-attributed grades and expanding capacity for healthcare, membrane and hydrogen-electrolyser applications.
Challenges and Opportunities
The market faces several challenges. Polysulfone is priced at a significant premium to standard engineering plastics and requires demanding processing conditions, which limits its use in price-sensitive applications. Its manufacture from bisphenol A exposes it to regulatory scrutiny, particularly following the European Union's restriction of bisphenols in food-contact materials adopted in 2024. Supply of key intermediates is concentrated, and substitution by polyethersulfone, polyphenylsulfone and other high-performance polymers constrains growth in certain niches.
At the same time, significant opportunities exist. Expanding dialysis and healthcare infrastructure in China, India, the Middle East and Latin America; investment in membrane-based water treatment, reuse and desalination; vehicle electrification; and demand for lower-carbon, bio-attributed grades all create avenues for growth. Producers that combine regulatory documentation, application-development support and local supply in high-growth markets are best positioned to capture these opportunities.
Future Outlook
The global polysulfone market is expected to grow steadily through 2032, with annual market value rising from USD 886.52 Million in 2026 to USD 1,266.78 Million in 2032. Growth will increasingly be driven by emerging economies: Asia Pacific's share of global value rises from 38.0% in 2025 to 40.1% in 2032. Medical & Healthcare will strengthen its position as the largest end-use industry, glass-filled grades and extrusion-based processes will gain share, and competition will intensify as Asian producers add capacity and established producers focus on high-specification and sustainable grades.
The Polysulfone Market market is projected to grow at a CAGR of 6.9% from 2022 to 2032.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansDefinition
Polysulfone (PSU) is an amorphous, transparent, high-performance thermoplastic belonging to the polyarylethersulfone family. It is produced by the polycondensation of bisphenol A with 4,4'-dichlorodiphenyl sulfone in a polar aprotic solvent, yielding a polymer backbone of aromatic rings linked by ether, isopropylidene and sulfone groups. The sulfone linkage confers high thermal and oxidative stability, while the ether linkages provide chain flexibility and toughness. Polysulfone has a glass-transition temperature of approximately 185°C, a continuous-use temperature of around 150°C, excellent hydrolytic stability in hot water and steam, inherent flame resistance, low creep, good dimensional stability and stable dielectric properties over a wide temperature and frequency range.
For the purpose of this study, the polysulfone market includes the value of polysulfone resins and compounds sold to processors, in unfilled and glass-filled grades, and converted by injection moulding, extrusion and other methods for use in the Medical & Healthcare, Electrical & Electronics, Automotive & Aerospace, and Water & Food Processing end-use industries. Market value is measured at the resin and compound level. The study excludes the value added by downstream conversion into finished parts, membranes, modules or devices; recycled and regrind material traded outside producer channels; and other polymers that are not polysulfone, such as polyphenylene sulfide (PPS), polyetheretherketone (PEEK), polyetherimide (PEI) and polycarbonate.
Scope of the Study
The study provides a quantitative and qualitative assessment of the global polysulfone market across the following dimensions:
Segmentations: By Grade (Unfilled; Glass-Filled), By End-Use Industry (Medical & Healthcare; Electrical & Electronics; Automotive & Aerospace; Water & Food Processing) and By Processing Method (Injection Molding; Extrusion & Others).
Regions and countries: North America (U.S., Canada, Mexico); Europe (Germany, U.K., France, Italy, Spain, Rest of Europe); Asia Pacific (China, India, Japan, Rest of Asia Pacific); Latin America (Brazil, Argentina, Rest of Latin America); and Middle East & Africa (UAE, Saudi Arabia, South Africa, Rest of MEA).
Timeline: historic years 2022, 2023 and 2024; base year 2025; forecast period 2026–2032. Compound annual growth rates (CAGR) are presented for 2026–2032.
Unit: all market values are presented in USD Million.
Competitive landscape: assessment of leading resin producers and compounders, competitor dashboard and key developments since 2022.
Research Objectives
To estimate the size of the global polysulfone market for 2022–2025 and forecast it for 2026–2032 in USD Million.
To analyse the market by grade, end-use industry and processing method, and to identify the largest and fastest-growing segments.
To assess regional and country-level demand across 20 country markets and to identify high-growth geographies.
To evaluate the drivers, restraints, opportunities, trends and challenges influencing polysulfone demand, including healthcare growth, water-treatment investment and vehicle electrification.
To analyse the polysulfone value chain from bisphenol A and dichlorodiphenyl sulfone through resin production and compounding to end users.
To examine the regulatory environment governing medical, food-contact, potable-water and chemical-safety compliance in major regions.
To profile the competitive structure of the market and to track product launches, capacity expansions, partnerships and corporate restructuring since 2022.
To provide strategic insights for resin producers, compounders, converters, investors and end users.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansOverview of the Research Process
The study follows a structured, multi-stage research process. It begins with defining the market and its segmentation, followed by extensive secondary research to build an understanding of the polysulfone value chain, production capacities, trade flows, pricing and end-use demand. Primary research with industry participants is then used to validate and refine the findings. Market size is estimated through top-down and bottom-up approaches, which are reconciled through data triangulation. The final stage consists of forecasting, internal quality review and consistency checks across segments, regions and countries.
Stage 1 – Market definition and scoping: definition of polysulfone, inclusions and exclusions, segmentation and geographic coverage.
Stage 2 – Secondary research: collection of data on capacities, production, trade, prices and application demand.
Stage 3 – Primary research: discussions with supply-side and demand-side participants to validate assumptions.
Stage 4 – Market estimation: top-down and bottom-up sizing and triangulation.
Stage 5 – Forecasting and validation: forecast modelling, sensitivity checks and final review.
Secondary Research
Secondary research draws on sources specific to the high-performance polymers and end-use industries relevant to polysulfone:
Industry associations: Plastics Europe, the Plastics Industry Association (PLASTICS), the American Chemistry Council, the European Chemical Industry Council (Cefic), the China Petroleum and Chemical Industry Federation, the Japan Plastics Industry Federation and AdvaMed and MedTech Europe for medical devices.
Government and regulatory bodies: the U.S. Food and Drug Administration, U.S. Environmental Protection Agency, U.S. Census Bureau and U.S. International Trade Commission, the European Chemicals Agency, the European Commission and Eurostat, China's National Medical Products Administration and Ministry of Industry and Information Technology, India's Department of Chemicals and Petrochemicals, and Japan's Ministry of Economy, Trade and Industry.
Trade statistics: import and export data under the Harmonized System code covering polysulfones (HS 3911.90) from national customs authorities and UN Comtrade.
Company filings: annual reports, investor presentations, sustainability reports, press releases and product literature of resin producers, compounders and membrane manufacturers.
Trade journals and technical literature: plastics and polymer trade publications, membrane-technology and medical-device journals, patent databases and conference proceedings.
Paid databases: company financial databases, chemical price-reporting services and trade-data platforms.
Primary Research
Primary research was conducted through in-depth telephone and online interviews and structured questionnaires with participants across the value chain. Its purpose was to validate secondary findings, obtain qualitative insights on market dynamics and refine estimates of market size, segment splits and growth rates.
Supply-side respondents: product managers, business-development heads, sales and marketing executives and technical-service specialists at polysulfone resin producers, compounders, distributors and stock-shape manufacturers.
Demand-side respondents: procurement managers, design and materials engineers at medical-device, membrane, electrical and electronics, automotive, aerospace and food-equipment manufacturers, and injection moulders and extruders.
Objectives: to validate market size and segmentation; understand pricing, capacity utilisation and supply constraints; assess substitution threats and qualification cycles; and gauge expectations for demand growth by application and region.
Market Size Estimation
Top-down approach: The global market was estimated from overall sulfone-polymer production capacity and output, adjusted for the share of polysulfone relative to polyethersulfone and polyphenylsulfone, and validated against trade data and the reported revenues of leading producers. The global value was then allocated to regions, countries and segments using shares derived from secondary research and primary interviews.
Bottom-up approach: Demand was estimated by application in each country, based on the production of end products such as dialysers, membrane modules, medical devices, electrical components, vehicles and food-processing equipment, multiplied by polysulfone consumption per unit and average selling prices by grade. Country estimates were aggregated to regional and global totals.
Data triangulation: The results of both approaches were compared and reconciled. Differences were investigated through additional secondary research and primary interviews until the estimates converged, ensuring that segment, country, regional and global values are mutually consistent.
Forecasting Methodology
The forecast combines statistical analysis of historic demand with an assessment of the factors expected to shape future demand. Key factors considered include growth in end-use industries (medical-device production, dialysis treatment volumes, water-treatment capacity, vehicle production and electrification, aircraft build rates and electronics output), GDP and industrial production, resin price trends, capacity additions, substitution between polysulfone and competing materials, and regulatory developments. Growth rates were applied at the country and segment level and adjusted on the basis of primary-research inputs. The forecast was cross-checked against the expansion plans of leading producers and the expected adoption of new applications.
Assumptions and Limitations
All values are expressed in nominal USD; currency conversions use average annual exchange rates for the historic years and constant rates for the forecast period.
The forecast assumes no major disruption to global supply of key raw materials, including bisphenol A and dichlorodiphenyl sulfone, and no significant new restrictions on polysulfone in its principal applications.
Macroeconomic conditions are assumed to follow consensus projections, with no prolonged global recession during the forecast period.
The market is measured at the resin and compound level; downstream conversion value is excluded.
Some producers do not separately disclose polysulfone revenues, and estimates for these companies rely on triangulation of capacity, pricing and interview data.
Country-level estimates for smaller markets aggregated as "Rest of" regions carry a higher degree of uncertainty than those for large individual countries.
Base Year
2025
Historical Period
2022 – 2024
Forecast Period
2026 – 2032
Primary Interviews
150+
Historical data (2022–2025) and forecast period (2025–2032)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansIntroduction
The global polysulfone market is moderately consolidated at the resin-production stage and fragmented downstream. Resin production requires proprietary polymerisation technology, access to high-purity monomers and long-standing regulatory qualifications, which has historically limited the number of global producers. Syensqo and BASF lead the market, with Sumitomo Chemical an established producer in Japan. Over the past decade, Chinese producers including Guangdong Youju, Kingfa and Shandong Horann have commissioned sulfone-polymer capacity, increasing competition in standard grades and in the Asia Pacific region.
Competition is based less on price than on grade breadth, regulatory documentation for medical, food-contact and potable-water applications, application-development support and supply reliability. Because qualification cycles in medical devices, dialysis membranes and aerospace are long, incumbent suppliers benefit from high switching costs. Downstream, a fragmented group of compounders, stock-shape manufacturers, colour-concentrate suppliers and distributors serves converters and original equipment manufacturers. Recent competitive activity has centred on capacity expansion, mass-balance and bio-attributed grades, applications in hydrogen electrolysers and electronics, and strengthening distribution in emerging markets.
Key Player Positioning
Leaders – Syensqo and BASF combine large-scale integrated production, the broadest sulfone portfolios (PSU, PESU and PPSU), global technical-service networks and deep regulatory files in medical, membrane and food-contact applications.
Challengers – Sumitomo Chemical, Guangdong Youju and Kingfa are resin producers with growing capacity and strong regional positions, particularly in Asia Pacific, and are expanding their presence in export markets.
Niche players – Shandong Horann is a smaller domestic resin producer, while Ensinger, Mitsubishi Chemical Group (MCAM), Röchling and Avient specialise in downstream conversion and formulation, including stock shapes, machined parts and high-temperature colorants for sulfone polymers.
Syensqo SA (Leader)
Headquartered in Brussels, Belgium, Syensqo was formed through the partial demerger of Solvay's specialty businesses, which took effect in December 2023, and is the largest established producer of sulfone polymers. The company reported net sales of EUR 6.14 billion for FY2025. Its sulfone portfolio comprises Udel PSU, including the Udel PSU ECHO circular-content grade, Veradel PESU and Radel PPSU, with U.S. polymer production at Marietta, Ohio and monomer production at Augusta, Georgia. Syensqo's strategy is to become a focused specialty-materials company with Specialty Polymers as a core pillar, expanding U.S. sulfone capacity, offering ISCC PLUS mass-balance drop-in grades and targeting haemodialysis, water-filtration membrane and green-hydrogen applications.
BASF SE (Leader)
Headquartered in Ludwigshafen, Germany, BASF is the world's largest diversified chemical company, with sales of EUR 59.66 billion in FY2025. It produces polyarylethersulfones under the Ultrason brand: Ultrason S (PSU), Ultrason E (PESU), Ultrason P (PPSU) and Ultrason D (PESU blends), together with biomass-balanced (BMB) grades produced in Ludwigshafen; it also operates Ultrason production in Yeosu, South Korea. Ultrason has been used in water-filtration and dialysis membranes for more than 25 years. BASF's strategy focuses on biomass-balanced drop-in grades, application development in water electrolysers, high-voltage and data-centre electronics, and metal and PFAS replacement, while defending its strong membrane and food-contact positions.
Sumitomo Chemical Co., Ltd. (Challenger)
Headquartered in Tokyo, Japan, Sumitomo Chemical is a diversified chemical company that reported revenue of JPY 2,328.5 billion for FY2025 (year ended March 2026). It is Japan's principal sulfone-polymer producer, marketing SUMIKAEXCEL PES, including glass-filled grades and PES micro-powders used to toughen epoxy carbon-fibre composites, produced at its Chiba Works. The company positions SUMIKAEXCEL for aerospace and automotive composites, metal replacement in e-mobility components such as e-motor housings, and sterilisation-resistant healthcare applications, as part of a broader group strategy of shifting its portfolio towards specialty materials.
Guangdong Youju Advanced New Materials Co., Ltd. (Challenger)
Founded in 2012 and based in Jiangmen, Guangdong, China, Youju is one of China's leading integrated sulfone-polymer producers, with upstream production of monomers including bisphenol S, dichlorodiphenyl sulfone and biphenol. Its latest publicly disclosed revenue, from its ChiNext IPO prospectus, is main-business revenue of CNY 333.39 million for FY2021, of which polysulfone and upstream products accounted for the vast majority. The company sells Paryls PSU, Paryls PES and Paryls PPSU, holds UL, NSF, WRAS, FDA and ISO 10993 certifications, and in 2024 disclosed polysulfone capacity of 6,000 tonnes per year plus a newly commissioned 5,000 tonnes-per-year line. Its strategy combines backward integration, rapid capacity build-out and export expansion through distribution partners.
Kingfa Sci. & Tech. Co., Ltd. (Challenger)
Founded in 1993 and headquartered in Guangzhou, China, Kingfa is China's largest modified-plastics producer, with revenue of CNY 65.40 billion in FY2025. It has integrated backwards into specialty polymer resins, including PPSU and PESU marketed under the Visulfon brand in unfilled, glass-fibre and carbon-fibre reinforced and coating grades. At its 2025 interim results briefing the company disclosed PPSU capacity of approximately 6,600 tonnes per year. Kingfa's strategy is to leverage its compounding scale and downstream relationships in consumer electronics, automotive, new energy and robotics to pull through its own specialty resins.
Shandong Horann Advanced Materials Co., Ltd. (Niche player)
Founded in 2010 and based in Weihai, Shandong, China, Horann is a specialty-polymer producer manufacturing PSU, PES, PPSU and PEEK resins. The company is privately held and does not publicly disclose its revenue. It supplies domestic Chinese processors in membrane, electrical and medical applications and is regarded as one of the emerging domestic alternatives to imported sulfone resins, competing primarily on price and local service.
Ensinger GmbH (Niche player)
Founded in 1966 and headquartered in Nufringen, Germany, Ensinger is a family-owned manufacturer of compounds, stock shapes, profiles and machined parts from engineering and high-performance plastics, with around 2,500 employees at more than 30 locations and revenue of more than EUR 500 million in FY2023/24. Its sulfone range includes TECASON S (PSU), TECASON E (PESU) and TECASON P (PPSU), including TECASON P MT biocompatible medical grades. Ensinger's strategy is to cover the chain from pellet to finished part for medical, food-processing, semiconductor and aerospace customers, supported by acquisitions and new product formats such as engineering particle foams.
Mitsubishi Chemical Group Corporation (Niche player)
Headquartered in Tokyo, Japan, Mitsubishi Chemical Group reported revenue of JPY 3,704.0 billion for FY2025 (year ended March 2026). Through Mitsubishi Chemical Advanced Materials (MCAM), it is a leading global producer of engineering-plastic stock shapes and machined components, including Duratron PSU and Duratron PPSU shapes for medical, semiconductor, food-processing and industrial applications. The group is reshaping its portfolio towards specialty materials under its KAITEKI Vision 35, while MCAM is investing in U.S. extrusion capacity for high-performance shapes.
Röchling SE & Co. KG (Niche player)
Röchling is a family-owned plastics group based in Mannheim, Germany, with sales of EUR 2.547 billion in FY2025, of which its Industrial division contributed EUR 1.138 billion. The Industrial division produces thermoplastic semi-finished products and machined components, including Sustason PSU and Sustason PPSU, with Sustason PPSU MG grades for sterilisable medical applications. Its strategy is to grow industrial semi-finished products and machined components through bolt-on acquisitions and a local-for-local international footprint.
Avient Corporation (Niche player)
Headquartered in Avon Lake, Ohio, USA, Avient is a specialty formulator of colorants, additives and engineered materials, with sales of USD 3.26 billion in FY2025. It supplies high-temperature colour concentrates and pre-coloured solutions for PSU, PESU and PPSU, notably its Transcend healthcare colorants designed to withstand repeated autoclave cycles, and has collaborated with BASF on sulfone colorants for Ultrason. Avient's strategy focuses on specialty formulations for healthcare and other regulated markets, helping device makers use sulfone polymers in colour-coded, repeatedly sterilised instruments.
Competitor Dashboard
The competitor dashboard rates each profiled company on four parameters on a scale of Low, Medium, High and Very High, based on product portfolio breadth in sulfone polymers, geographic reach, the extent of strategic partnerships and distribution alliances, and years of experience in high-performance polymers.
Threat of New Entrants – Low
Production requires proprietary polymerisation technology, high-purity monomers and significant capital investment in plants that handle high-temperature solvent processes.
Lengthy qualification and regulatory approval in medical, aerospace and potable-water applications favour incumbent suppliers.
New Asian entrants have emerged, but mainly in standard grades, and remain challenged in high-specification segments.
Bargaining Power of Suppliers – Medium
Bisphenol A is widely available, but DCDPS supply is concentrated among few producers, some of which are vertically integrated resin makers.
Energy and solvent costs affect production economics and can be passed on only partially.
Bargaining Power of Buyers – Medium
Large dialyser and membrane producers and automotive suppliers purchase substantial volumes and negotiate long-term contracts.
Switching costs are high once a grade is qualified, limiting buyers' ability to change supplier.
Smaller converters have little negotiating power and rely on distributors.
Threat of Substitutes – Medium
PESU and PPSU replace polysulfone where higher heat or chemical resistance is required, often from the same producers.
Polycarbonate, polyetherimide, PPS, polyamides and liquid-crystal polymers compete in specific electrical and automotive applications.
Few materials match polysulfone's combination of transparency, hydrolytic stability and sterilisability, limiting substitution in medical and membrane uses.
Intensity of Competitive Rivalry – High
The market is led by a small number of global producers that compete on technical service, grade breadth and regulatory documentation.
Capacity expansion by Chinese and Indian producers increases price competition in standard grades.
Producers differentiate through specialised medical, membrane and sustainable grades.
Threat of New Entrants: Low.
Bargaining Power of Suppliers: Medium.
Bargaining Power of Buyers: Medium.
Threat of Substitutes: Medium.
Intensity of Competitive Rivalry: High.
Market estimates by geography (2032)
InsightAsia Pacific leads with $507.98M by 2032, while Middle East & Africa is projected to grow fastest at a 8.5% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2022 | 2025 | 2032 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $197.46M | $281.29M | $366.73M | 6.4% | 29% |
| Europe | $185.46M | $261.40M | $336.96M | 6.2% | 27% |
| Asia Pacific | $240.58M | $365.58M | $507.98M | 7.8% | 40% |
| Latin America | $12.58M | $19.32M | $27.11M | 8.0% | 2% |
| Middle East & Africa | $12.39M | $19.51M | $28.00M | 8.5% | 2% |
| Total | $648.46M | $947.10M | $1.27B | 6.9% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$1.27B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Unfilled | $737.90M | 6.5% | 58% |
| Glass-Filled | $528.88M | 7.6% | 42% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Polysulfone Market covering market dynamics, competitive landscape, and strategic outlook.
The Polysulfone Market market is projected to reach $1.27B by 2032, growing at 6.9% CAGR. The Unfilled segment holds the largest share.
The global polysulfone market grew from USD 648.46 Million in 2022 to USD 828.66 Million in 2025 and is projected to reach USD 1,266.78 Million by 2032, a CAGR of 6.13% during 2026–2032. This chapter examines the forces shaping that trajectory. Demand is fundamentally linked to structural trends in healthcare, water treatment, electrification and electronics, while raw-material costs, regulatory scrutiny of bisphenol-based polymers and competition from alternative materials act as moderating factors.
Rising Demand for Haemodialysis and Medical Devices
Medical & Healthcare is the largest end-use industry for polysulfone, valued at USD 248.60 Million in 2025, and it is also the fastest-growing at a CAGR of 6.89%. The single most important application is the hollow-fibre membrane used in haemodialysers, which are typically spun from polysulfone or polyethersulfone blended with polyvinylpyrrolidone. Chronic kidney disease affects roughly one in ten adults worldwide, and the number of patients receiving dialysis continues to grow with ageing populations and rising prevalence of diabetes and hypertension. Each patient on haemodialysis typically uses around 150 dialysers a year where single use is standard, creating a large, recurring consumable demand. Beyond dialysis, polysulfone's ability to withstand repeated steam autoclaving and chemical sterilisation makes it the material of choice for sterilisation trays, surgical instrument handles and reusable device housings. Governments in China, India, Saudi Arabia and Brazil are expanding dialysis access through public programmes, and dialyser producers are adding capacity in these countries, which directly increases resin demand.
Investment in Water Treatment, Reuse and Desalination
Water & Food Processing accounted for 25.0% of global polysulfone value in 2025. Polysulfone and polyethersulfone are leading polymers for ultrafiltration and microfiltration membranes used in drinking-water treatment, wastewater reuse and desalination pre-treatment, owing to their chlorine tolerance, wide pH resistance and mechanical strength. Regulatory tightening is accelerating membrane adoption: the recast EU Drinking Water Directive (EU) 2020/2184 strengthens quality standards, the U.S. Infrastructure Investment and Jobs Act of 2021 allocated substantial funding to water infrastructure, and water-stressed countries in the Middle East, Asia and Latin America are investing heavily in desalination and municipal reuse. In the Middle East & Africa, Water & Food Processing represents 44.0% of regional demand. In parallel, food-processing and dairy equipment manufacturers specify polysulfone for parts exposed to hot cleaning-in-place cycles, while plumbing-fitting producers use it in hot-water systems where long-term hydrolytic stability is required.
Vehicle Electrification and Lightweighting
The Automotive & Aerospace end-use industry was valued at USD 165.73 Million in 2025 and is projected to grow at a CAGR of 6.02%. Battery-electric and hybrid vehicles contain significantly more high-voltage connectors, sensors, busbar insulators, battery-module components and thermal-management parts than conventional vehicles, and these components require materials with high continuous-use temperatures, flame retardancy and dimensional stability, which glass-filled polysulfone grades provide. Corporate average fuel economy and CO₂ fleet-emission regulations in the United States, European Union and China continue to reward weight reduction, encouraging the replacement of metal parts with high-performance thermoplastics. In China, Automotive & Aerospace is the fastest-growing end-use industry, with a CAGR of 10.24%. In aerospace, recovering commercial aircraft build rates and cabin refurbishment programmes sustain demand for sulfone polymers that meet aircraft fire, smoke and toxicity requirements.
Growth of Electronics Manufacturing and Electrical Infrastructure
Electrical & Electronics accounted for 25.0% of global polysulfone value in 2025 and is the largest end-use industry in Asia Pacific, where it represents 34.7% of regional demand. Polysulfone's stable dielectric properties, inherent flame resistance and ability to withstand lead-free soldering temperatures make it suitable for connectors, coil bobbins, relays, circuit-breaker components and capacitor films. Investment in power distribution, renewable-energy inverters, electric-vehicle charging infrastructure and data centres is increasing demand for high-reliability electrical components. Government programmes such as the U.S. CHIPS and Science Act, the European Chips Act and India's semiconductor and electronics manufacturing incentives are expanding electronics production capacity, which in turn supports demand for high-performance thermoplastics used in components and in semiconductor-processing equipment.
Expansion in Emerging Healthcare Markets
Healthcare infrastructure investment in Asia Pacific, the Middle East and Latin America presents the most significant growth opportunity. Medical & Healthcare grows at a CAGR of 10.42% in India and 10.11% in China during 2026–2032. Localisation of dialyser, bioprocessing and medical-device manufacturing, supported by incentive programmes, creates demand for qualified medical-grade resins and opportunities for producers to establish local technical service and compounding capabilities.
Bio-Attributed and Circular Grades
Brand owners in medical, food-service and consumer markets are seeking lower-carbon materials. Mass-balance, bio-attributed and recycled-content sulfone grades certified under schemes such as ISCC PLUS allow producers to offer drop-in materials with reduced product carbon footprints and without requalification of part designs. Producers that can document lower lifecycle emissions are positioned to win specifications as customers pursue Scope 3 emission targets.
Membranes for Bioprocessing, Hydrogen and Industrial Separation
Beyond dialysis and water treatment, polysulfone membranes are used in biopharmaceutical filtration, gas separation and emerging hydrogen and battery-related applications. Growth in biologics manufacturing and industrial water recycling expands the addressable market for solution-spun membranes, supporting the Extrusion & Others segment, which grows at a CAGR of 6.82%.
High Material and Processing Costs
Polysulfone is priced at a substantial premium to commodity and standard engineering plastics such as polycarbonate, polyamides and PBT. Processing requires melt temperatures of roughly 330°C to 400°C, careful drying and heated moulds, which raise energy use and require experienced converters. In price-sensitive applications, particularly consumer electrical goods and non-critical automotive parts, these costs encourage the use of lower-cost alternatives, which explains why Electrical & Electronics is the slowest-growing end-use industry, at a CAGR of 5.61%.
Regulatory Scrutiny of Bisphenol A
Polysulfone is manufactured from bisphenol A, which has been classified in the European Union as toxic for reproduction and identified as a substance of very high concern for its endocrine-disrupting properties. In December 2024, the European Commission adopted Regulation (EU) 2024/3190, restricting the use of bisphenol A and other hazardous bisphenols in food-contact materials. Even where specific derogations or limited migration allow continued use, this scrutiny raises compliance costs, prompts some brand owners to seek bisphenol-free alternatives such as polyphenylsulfone, and adds uncertainty to food-contact and consumer applications.
Competition from Other High-Performance Polymers
Polysulfone competes with closely related sulfone polymers, including polyethersulfone (PESU) and polyphenylsulfone (PPSU), which offer higher heat and chemical resistance, and with polyetherimide, polyphenylene sulfide and liquid-crystal polymers in electrical applications. As processing technology improves and prices of alternatives decline, some applications migrate away from polysulfone, constraining its growth in specific niches.
Challenge: Supply-Chain Concentration and Raw-Material Volatility
Production of polysulfone and its key intermediate, dichlorodiphenyl sulfone, is concentrated among a small number of producers. Plant outages, logistics disruptions and fluctuations in bisphenol A and energy prices can lead to supply tightness and price volatility, affecting converters with limited ability to switch materials because of lengthy qualification processes.
Challenge: Long Qualification Cycles
Medical, aerospace and potable-water applications require extensive testing and certification, often taking several years. While this creates stickiness for incumbent materials, it slows the adoption of new grades and suppliers and raises barriers for new entrants seeking to compete on price.
Trend: Shift Towards Glass-Filled and Engineered Compounds
Glass-filled grades grow at a CAGR of 6.78%, faster than unfilled grades at 5.68%, as designers replace metal in structural and electrical parts. Compounders are developing tailored formulations with specific fibre loadings, colours and laser-marking capability to meet application requirements.
Trend: Rise of Asian Production Capacity
Chinese and Indian producers have expanded polysulfone and polyethersulfone capacity, increasing regional self-sufficiency and putting pressure on prices in commodity grades. Western producers are responding by concentrating on high-specification medical, aerospace and membrane grades and by strengthening technical service.
The polysulfone value chain comprises four principal stages, from petrochemical intermediates to end-use industries. Value is concentrated at the resin-production stage, where a small number of producers control polymerisation technology, while compounders and converters add value through formulation and processing.
Raw Materials and Inputs
The primary monomers are bisphenol A, derived from phenol and acetone, and 4,4'-dichlorodiphenyl sulfone (DCDPS), produced from chlorobenzene and sulfur-based reagents. Polymerisation also requires potassium carbonate or other bases and polar aprotic solvents such as N-methyl-2-pyrrolidone, sulfolane or dimethylacetamide. Glass fibre, stabilisers, pigments and processing aids are used in compounding. The availability and cost of DCDPS, which is produced by a limited number of suppliers, is a key determinant of supply security.
Manufacturing
Resin producers manufacture polysulfone through nucleophilic aromatic substitution polycondensation at elevated temperature, followed by solvent removal, washing, devolatilisation and pelletising. Producers sell neat resin and may also compound glass-filled grades. Independent compounders then produce reinforced, coloured and specialty formulations, and stock-shape manufacturers extrude rods, plates and tubes for machining. Membrane manufacturers dissolve polysulfone in solvents and spin hollow fibres or cast flat sheets.
Distribution and Channels
Large customers, such as dialyser producers, membrane manufacturers and tier-one automotive suppliers, typically purchase directly from resin producers under long-term supply agreements. Smaller moulders and extruders are served through specialty-plastics distributors, which provide inventory, small-lot packaging and technical support. Stock shapes and semi-finished products are sold through engineering-plastics distributors and machine shops.
End Users
End users include manufacturers of medical devices and dialysers, water-treatment membrane modules, plumbing and food-processing equipment, electrical and electronic components, automotive parts and aircraft interiors. Their material specifications, qualification requirements and regulatory approvals strongly influence supplier selection and create long-term customer relationships.
North America
21 CFR 177.1655 (U.S. FDA): specifies polysulfone resins that may be safely used as articles or components of articles intended for repeated use in contact with food.
21 CFR Part 820 (Quality Management System Regulation): governs quality systems for medical-device manufacturers; the amended regulation incorporating ISO 13485:2016 took effect in February 2026.
Toxic Substances Control Act (TSCA): administered by the U.S. Environmental Protection Agency, regulating chemical substances including monomers and solvents used in polysulfone production.
14 CFR 25.853 (Federal Aviation Administration): flammability requirements for compartment interiors of transport-category aircraft.
NSF/ANSI/CAN 61: health-effects standard for drinking-water system components, widely required for plumbing and water-treatment parts in the U.S. and Canada.
Europe
REACH Regulation (EC) No 1907/2006 and CLP Regulation (EC) No 1272/2008: chemical registration, evaluation and classification, including the classification of bisphenol A.
Medical Device Regulation (EU) 2017/745: requirements for clinical evaluation, biocompatibility and documentation of medical devices.
Regulation (EC) No 1935/2004 and Regulation (EU) No 10/2011: framework and specific rules for plastic materials and articles intended to come into contact with food.
Regulation (EU) 2024/3190: restrictions on bisphenol A and other hazardous bisphenols in food-contact materials and articles.
Drinking Water Directive (EU) 2020/2184: harmonised hygiene requirements for materials in contact with drinking water.
RoHS Directive 2011/65/EU: restriction of hazardous substances in electrical and electronic equipment.
Asia Pacific
China – GB 4806.6-2016 and GB 4806.7-2016: national food-safety standards for plastic resins and plastic materials and articles in contact with food.
China – Regulations on the Supervision and Administration of Medical Devices (State Council Order No. 739): framework for medical-device registration administered by the National Medical Products Administration.
Japan – Food Sanitation Act positive-list system: applies to synthetic resins used in food utensils, containers and packaging, fully effective from June 2020.
Japan – Pharmaceuticals and Medical Devices Act: governs approval and quality of medical devices.
India – Medical Devices Rules, 2017: licensing and quality requirements for medical devices administered by the Central Drugs Standard Control Organisation.
Latin America and Middle East & Africa
Brazil – ANVISA: regulates medical-device registration and food-contact materials through technical resolutions aligned with MERCOSUR requirements.
Saudi Arabia – Saudi Food and Drug Authority (SFDA): regulates medical devices and food-contact materials, including marketing authorisation for medical devices.
Gulf Cooperation Council – GSO standards: harmonised technical regulations for food-contact materials and products traded across GCC member states.
International Standards
ISO 10993 series (biological evaluation of medical devices), USP Class VI (plastics biological reactivity testing), ISO 13485 (medical-device quality management) and UL 94 (flammability of plastic materials) are widely referenced in polysulfone grade specifications.
Apr 2022: Avient; Product launch; Launched Transcend healthcare high-temperature colorants for PPSU, rated for 1,000 autoclave cycles and tested to ISO 10993, with PESU and PSU versions in development.
Oct 2022: Guangdong Youju; Expansion; Updated its ChiNext IPO prospectus, outlining a 16,000 tonnes-per-year specialty plastics project including 6,000 tonnes per year of PSU.
Dec 2022: Ensinger; Acquisition; Ensinger PolyTech acquired the assets of Poly-Tech Industrial (Huntersville, North Carolina) to strengthen its high-performance "pellet to part" offering.
Apr 2023: Solvay (now Syensqo); Product launch; Launched ISCC PLUS mass-balance certified Udel PSU and Radel PPSU produced at Marietta, Ohio, and announced plans to raise PSU capacity by 25%.
Dec 2023: Syensqo; Corporate restructuring; Completed the partial demerger from Solvay and began trading on Euronext Brussels and Paris as an independent specialty-materials company.
Sep 2024: Sumitomo Chemical; Product promotion; Presented SUMIKAEXCEL PES at Fakuma 2024 as a metal-replacement material for e-motor housings and for medical applications.
Oct 2024: BASF; Application development; Positioned Ultrason PSU, PESU and PPSU for frames, gaskets and separator membranes in alkaline, PEM and AEM water electrolysers.
Oct 2024: Guangdong Youju; Partnership; Signed a global distribution agreement with Redox and disclosed a newly commissioned 5,000 tonnes-per-year polysulfone line.
Nov 2024: Syensqo; Expansion; Increased Udel PSU production capacity at Marietta, Ohio by more than 25% to serve haemodialysis, water-filtration and green-hydrogen markets.
Mar 2025: BASF; Product launch; Launched Ultrason E 2010 BMB, a biomass-balanced, ISCC PLUS certified PESU produced in Ludwigshafen.
Mar 2025: BASF; Product launch; Introduced Ultrason D 1010 G6 U40, a high-flow, halogen-free flame-retardant PESU blend for electrical, electronic and semiconductor parts.
Apr 2025: Syensqo; Partnership; Agreed with Nitto Denko to use mass-balance certified Udel PSU ECHO in Nitto's water-treatment membranes.
Sep 2025: BASF; Partnership; Stargate Hydrogen adopted Ultrason S PSU for the stack frames of its alkaline water electrolysers.
Sep 2025: Kingfa; Expansion; Disclosed PPSU capacity of about 6,600 tonnes per year and a 50,000 tonnes-per-year specialty plastics compounding plant under construction.
Nov 2025: Ensinger; Product launch; Launched engineering particle foams based on PEEK, PESU and PC for aerospace, electronics and medical applications.
Feb 2026: Röchling; Acquisition; Röchling Industrial agreed to acquire the operating business of Terbrack Kunststoff (Vreden, Germany), effective March 2026, adding capacity for pressed thermoplastic semi-finished products.
Mar 2026: BASF; Product launch; Launched Ultrason P 3010 BMB, a PPSU with attributed bio-circular feedstock for baby bottles, drinking-water and medical applications.
Jul 2026: Mitsubishi Chemical Group (MCAM); Expansion; Announced a USD 20.3 million investment to expand its Reading, Pennsylvania site as a centre of excellence for extruding advanced engineering plastics.
Political
Trade tensions and tariffs between the United States and China affect the cost and flow of specialty resins and intermediates.
Industrial policies promoting domestic medical-device and semiconductor manufacturing, such as India's PLI schemes and China's localisation programmes, support regional demand.
Economic
Healthcare spending growth and infrastructure investment in emerging economies drive demand, while slower growth in Europe and Japan moderates mature markets.
Energy and feedstock price volatility affects production costs, particularly for European producers.
Currency fluctuations influence import costs in Latin America and Africa.
Social
Ageing populations and rising prevalence of chronic kidney disease increase demand for dialysis and medical devices.
Growing awareness of water quality supports home and municipal water-purification systems.
Technological
Advances in membrane spinning, high-flux dialysers and additive-manufacturing filaments expand application potential.
Development of bio-attributed, glass-filled and specialty compounds broadens the product range.
Simulation-led design enables metal replacement in complex parts.
Environmental
Pressure to reduce carbon footprints encourages mass-balance and recycled-content grades and energy-efficient production.
Water scarcity drives investment in desalination and reuse, which are key applications for polysulfone membranes.
Legal
Restrictions on bisphenol A in food-contact applications in the European Union create compliance requirements.
Medical-device regulations such as EU MDR and the U.S. QMSR raise documentation and qualification requirements for material suppliers.
Profiles of 105 companies operating in the Polysulfone Market market, including revenue, employee count, and market positioning where available.
Showing 105 of 105 companies
Avient Corporation is a mid-capitalisation specialty polymer formulator that occupies the value-added layer between commodity resin producers and the designers, assemblers and processors who convert polymers into finished goods. It does not make base resin. It buys polyolefins, engineering thermoplastics, titanium dioxide, pigments, specialty additives and ethylene, and sells formulated colour concentrates, functional additive masterbatches, engineered compounds, advanced composites and ultra-high-molecular-weight polyethylene (UHMWPE) fibre. Roughly 61% of 2025 sales were to customers outside the United States, and no single customer accounted for more than 3% of consolidated revenue — a diversification profile that materially dampens single-account risk but also means the business is a fairly direct read on global industrial production. The company has spent fifteen years divesting cyclical, capital-intensive commodity businesses (PVC compounds, performance products and solutions, distribution) and buying formulation and fibre assets (ColorMatrix, Spartech, Fiber-Line, Clariant Masterbatch, Dyneema). Under Ashish Khandpur, who arrived from 3M in December 2023, the emphasis has shifted decisively from portfolio reshaping via M&A to organic growth through innovation in a defined set of "growth vectors" — principally defence, healthcare, telecommunications and sustainable packaging — supported by relentless productivity work. The result through mid-2026 is a company with flat-to-modest top-line growth but three consecutive years of adjusted margin expansion and de-leveraging. Note: FY2021 and FY2023 site counts are as disclosed in the respective 10-Ks; the FY2021 figure includes the Distribution business footprint and is not strictly comparable. Regional headcount mix at 31 December 2025: US and Canada 33%, EMEA 33%, Asia 26%, Latin America 8%. --- ### The company's own characterisation Avient describes itself in the FY2025 Form 10-K as "an innovator of materials solutions to help our customers succeed, while enabling a sustainable world," with products spanning specialty engineered materials, performance fibres, advanced composites, and colour and additive solutions, plus performance-enhancing additives, liquid colorants and silicone colorants. Management frames the company's role as creating "an essential link between large chemical producers (our raw material suppliers) and designers, assemblers and processors of polymers (our customers)," arguing that this intermediary role becomes more valuable as customers demand global reach with local service and materials-based solutions that improve product performance, appeal, differentiation and profitability. ### Independent characterisation Avient is best understood as a formulation and applications-engineering business with a fibre franchise attached. Three structurally distinct profit pools sit under two reporting segments: **Pool 1 — Colour and additive masterbatch (the bulk of Color, Additives and Inks).** High-mix, low-volume, short-lead-time concentrates sold into packaging, consumer, healthcare and industrial converters. Value is created through colour matching, formulation know-how, regulatory qualification (particularly in healthcare and food contact), and local service density. Switching costs are moderate but real, because a colour or additive package is written into a customer's specification and requalification is costly. Gross margins here are structurally attractive (segment gross margin 33.5% in FY2025) but the business is closely levered to converter volumes and therefore to consumer and industrial demand. **Pool 2 — Engineered compounds and composites (most of Specialty Engineered Materials ex-Dyneema).** Longer development cycles, deeper specification lock-in, and more exposure to transportation, telecommunications, electrical/electronics, healthcare devices and building products. Products such as flame-retardant and low-smoke compounds (ECCOH), thermally and electrically conductive formulations (Therma-Tech, Stat-Tech), low-loss dielectrics (PREPERM) and long-fibre reinforced thermoplastics (Complēt) are designed into parts and generate multi-year revenue annuities. **Pool 3 — Avient Protective Materials / Dyneema.** A genuinely differentiated, capacity-constrained UHMWPE fibre and unidirectional-laminate business acquired from DSM in 2022. It has the strongest brand, the highest barriers to entry (polymer chemistry plus gel-spinning process know-how), and the most attractive secular demand backdrop of anything Avient owns, driven by NATO and allied defence re-armament, law-enforcement personal protection, offshore mooring and floating offshore wind. This is where incremental capital is being directed in 2026. ### Revenue model Avient's revenue is essentially 100% product sale revenue. There is no material subscription, licensing or service revenue stream disclosed. Revenue is recognised at a point in time when control transfers, typically on shipment; sales are reduced for volume-based customer rebates estimated at the time of initial sale. Services such as ColorWorks design centres, the CycleWorks recycling innovation centre, colour-prediction and foaming-prediction tools, part and tooling design analysis, and 3D printing/rapid prototyping are offered as commercially bundled, non-separately-monetised demand-generation assets rather than fee-bearing lines. A small equipment element exists (ColorMatrix FlexCart and FlexOne liquid metering systems), typically placed to lock in liquid colorant consumption; standalone equipment revenue is not publicly disclosed. Pricing is negotiated account-by-account, with raw-material pass-through mechanisms of varying formality. Management commentary in 2026 has repeatedly emphasised proactive pricing actions ahead of inflation, and Q2 2026 organic growth of 4.3% was attributed to a combination of share gains, new product innovation and pricing. ### Route to market and value-chain position Products are sold primarily through a direct sales force, supplemented by distributors and commissioned sales agents. Logistics is predominantly truck-based, with some customer pickup. The value chain runs: base resin producers (LyondellBasell, Dow, ExxonMobil, SABIC, BASF and others) → Avient formulation → converters and moulders → OEMs and brand owners. Avient's commercial leverage comes from being specified at the OEM/brand-owner level while selling to the converter — a "pull-through" model common in specialty additives. ### Customer types and end markets Customers are plastics processors (injection moulders, extruders, blow moulders, film and fibre producers), tier-one automotive and aerospace suppliers, medical device and pharmaceutical packaging manufacturers, wire and cable makers, body-armour and defence primes, and rope, netting and mooring fabricators. Nine end markets are disclosed. The FY2024 mix, the most recently published full breakdown, was: Seasonality is modest but real: demand has historically been slower in the third and fourth quarters, and the defence business is tender- and project-driven, producing lumpy quarter-to-quarter order patterns.
BASF is the world's largest chemical company by sales, built on the Verbund principle of physically and energetically integrated production sites that turn a handful of feedstocks into thousands of products. Since September 2024 it has run under the "Winning Ways" strategy, which splits the portfolio into four core segments (Chemicals, Materials, Industrial Solutions, Nutrition & Care) that stay integrated, and standalone businesses (Agricultural Solutions, Battery Materials, Environmental Catalyst and Metal Solutions, and the now-divested Coatings) that are being monetized or prepared for capital-market options. In 2025 it generated €59.7 billion in sales and €6.6 billion in EBITDA before special items, a cyclical trough. In 2026 it closed the €7.7 billion Coatings transaction, started up its €-multi-billion Zhanjiang Verbund site, raised earnings guidance, and approached Evonik about a takeover. The investment debate is whether structural cost cuts and portfolio proceeds can restore returns above the cost of capital. --- **The company's own description.** BASF describes its purpose with the line "we create chemistry for a sustainable future" (BASF news release boilerplate, 2026) and states its ambition to be the preferred chemical company for enabling customers' green transformation. It reports around 108,000 employees, customers in nearly every sector and almost every country, and sales of around €60 billion in 2025. The portfolio is described as four core segments plus standalone businesses bundled in Surface Technologies and Agricultural Solutions. **Independent characterization.** BASF is best understood as three businesses under one roof: 1. **An integrated commodity and intermediates engine** (Chemicals, the Monomers half of Materials). This is a steam-cracker-to-derivatives chain selling ethylene and propylene derivatives, isocyanates, polyamide precursors and intermediates on spread economics. Earnings are driven by feedstock and energy costs, operating rates and regional supply-demand. It is the most capital-intensive part of the group and the main source of the 2023–2025 earnings decline: Chemicals EBITDA before special items fell from €1,342 million in 2024 to €853 million in 2025 (Factsheet FY2025). 2. **Formulated and performance products** (Performance Materials, Industrial Solutions, Nutrition & Care). These sell on specification and performance to automotive, construction, packaging, consumer goods, pharma and nutrition customers. Margins are steadier but have come under pressure from Asian competition and, in Care Chemicals, from consumer trading-down to private-label products (Factsheet FY2025 commentary). 3. **Standalone franchises** with different industry logic: Agricultural Solutions (crop protection, seeds and traits, digital farming), ECMS (emissions catalysts plus precious-metal trading and recycling) and Battery Materials. Agricultural Solutions is the group's highest-margin segment at 21.7% EBITDA margin before special items in FY2025 and the largest single earnings contributor at €2,081 million. **Revenue model.** Revenue is almost entirely product sales under supply contracts and spot transactions. There is no subscription model of consequence; digital farming (xarvio) and licensing of process technology and catalysts are small. Seeds and traits include royalty and licensing income within Agricultural Solutions, not separately disclosed. Precious-metal trading inflates ECMS sales (€7,978 million in FY2025) with pass-through metal value, which is why BASF quotes group margins both including and excluding metals (12.3% excluding metals in FY2025 per the CFO on the February 27, 2026 call, versus 11.0% reported). **Value chain position.** Upstream to midstream in petrochemicals with captive crackers at Ludwigshafen, Antwerp, Port Arthur (joint venture with TotalEnergies), Nanjing (joint venture with Sinopec) and Zhanjiang; midstream to downstream in engineering plastics, polyurethane systems, dispersions, additives, surfactants and vitamins; branded and channel-driven in agriculture. BASF exited upstream oil and gas operations when Wintershall Dea's E&P business was transferred to Harbour Energy in September 2024. **Customers and end-markets.** BASF serves industrial customers in chemicals and plastics, transportation, construction, consumer goods, agriculture, electronics, energy and resources, and health and nutrition. Intersegment transfers are large (Chemicals transferred €3,432 million internally in FY2025 on €10,055 million of third-party sales), which shows how much of the upstream output feeds BASF's own downstream chains.
4 interactive charts drawn from the Polysulfone Market dataset — market size, regional splits and each segment breakdown. Open one to read its full data table and download it.
Global Polysulfone Market By Processing Method
Global Polysulfone Market By End-Use Industry
Global Polysulfone Market By Grade
Global Polysulfone Market By Region
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Historical performance and future projections (2020–2030, USD Billion)
Market Size (USD Million)